Nektar Therapeutics NKTR Increase (Decrease) in Other Operating Assets
Increase (Decrease) in Other Operating Assets at other companies
Other financials
Where this comes from
Reported directly by Nektar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingAssets.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's increase (decrease) in other operating assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nektar Therapeutics's increase (decrease) in other operating assets?
- Nektar Therapeutics (NKTR) reported increase (decrease) in other operating assets of -$949K in Q1 2026.
- How has Nektar Therapeutics's increase (decrease) in other operating assets changed year-over-year?
- Nektar Therapeutics's increase (decrease) in other operating assets decreased by 115.9% year-over-year, from $5.96M to -$949K.
- What is the long-term trend for Nektar Therapeutics's increase (decrease) in other operating assets?
- Over 2 years (2021 to 2025), Nektar Therapeutics's increase (decrease) in other operating assets has grown at a 152.1% compound annual growth rate (CAGR), from $2.59M to $16.43M.
- What does increase (decrease) in other operating assets mean?
- This captures the net change in miscellaneous assets that are not classified as loans, securities, or property, plant, and equipment. It often includes items like accrued interest receivables, prepaid expenses, and other short-term operational assets.